Actos Lawyers at Bernstein Liebhard LLP Note Upcoming Status Conference in Federal Actos Bladder Cancer Lawsuits

Share Article

The Firm is currently investigating Actos lawsuits on behalf of individuals who developed bladder cancer, allegedly due to long-term use of the type 2 diabetes drug.

Bernstein Liebhard LLP | Consumer Injury Lawyers
Our Firm continues to receive Actos lawsuit inquiries from long-term users of the drug who developed bladder cancer. We look forward to more progress in this litigation in the coming months.

The Actos lawyers at Bernstein Liebhard LLP note that the next Status Conference for thousands of Actos lawsuits currently pending in U.S. District Court, Western District of Louisiana, has been scheduled for May 28th. Court records indicate that Takeda Pharmaceuticals has been named in more than 3,000 Actos lawsuits, most of which have been filed in the Louisiana litigation. All of the claims allege that long-term users of the type 2 diabetes drug face an increased risk of developing bladder cancer, and accuse Takeda Pharmaceuticals and other defendants of concealing their knowledge of that risk and failing to provide adequate warnings to the public and medical community. (In re: Actos Product Liability Litigation, MDL No. 2299)

“Our Firm continues to receive Actos lawsuit inquiries from long-term users of the drug who developed bladder cancer. We look forward to more progress in this litigation in the coming months,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm’s Actos lawyers are currently offering free legal evaluations to alleged victims of this medication.

Actos Bladder Cancer Lawsuits
Actos has been the subject of growing litigation since June 2011, when the U.S. Food & Drug Administration (FDA) ordered Takeda to add new warnings to the Actos label, after a study found that long-term use of the drug increased the risk for bladder cancer.* According to, Actos was also pulled from the market in Germany and France that month because of its association with bladder cancer. That same year, the drug accounted for 27 percent of Takeda’s sales.**

Earlier this month, closing statements were delivered in the nation’s first trial involving an Actos lawsuit, with the Plaintiff’s attorney telling a Los Angeles Superior Court jury that Takeda Pharmaceuticals hid the risk to protect billions of dollars in profits. According to Bloomberg, evidence introduced at trial included internal Takeda emails that suggested company officials were worried about the impact an Actos bladder cancer warning would have on sales of the drug. “Actos is the most important product for Takeda and therefore we need to manage this issue very carefully and successfully not to cause any damage for this product globally,” a Takeda executive wrote in 2005. Such a development would be a “worst case scenario,” and he urged colleagues to seek a “positive outcome” from “regulatory authorities.”** Jury deliberations are currently ongoing in that case. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)

Actos users who developed bladder cancer may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing an Actos bladder cancer lawsuit by visiting Bernstein Liebhard LLP’s website. For additional information, please contact an Actos lawyer at Bernstein Liebhard LLP today by calling (877) 779-1414.



About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website